By Eugene L. Heyden, RN “Given the high prevalence and rising incidence of non-alcoholic fatty liver disease (NAFLD), the absence of approved therapies is striking. Although the mainstay of treatment of NAFLD is weight loss, it is hard to maintain, prompting the need for pharmacotherapy as well.”   ~Rotman and Sanyal, 2017 I’ve seen this…